ARCHIVES

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

This article is from The Cancer Letter archive.

Vol. 24 No. 34 | September 11, 1998

Download PDF Visit The Full Archive

Related Articles

UPCC Wins $26 Million Center Grant From NCI; Massey Center Opens New Outpatient Clinic.

October 20, 2000

Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival

October 29, 2010

NCI-Approved CTEP Trials For the Month of November

November 30, 2012

Von Eschenbach To Leave FDA Jan. 20, Says He Was “In Love” With The Agency.

December 19, 2008

Alimta Reduces Risk Of Progression In Patients Aged 70 Years or Older

October 28, 2011

Bypass Budget Omits Needless Words: Faster Progress to Cost $421 Million More

March 29, 1996